Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	IKZF3 ZNF573 ZSCAN31 PEG3 JDP2 ZBTB41 ZNF395 CREB1 ATF6B CREM RXRA RXRB HOXA13 ZSCAN32 SOHLH2 SMARCA4 CCAR1 ZNF808 MAFB ATF1 TAF1	3.86e-06	1459	95	21	GO:0000977
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	IKZF3 ZNF573 ZSCAN31 JDP2 ZBTB41 ZNF395 CREB1 ATF6B CREM RXRA RXRB HOXA13 ZSCAN32 SOHLH2 SMARCA4 CCAR1 ZNF808 MAFB ATF1	5.23e-06	1244	95	19	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	IKZF3 ZNF573 ZSCAN31 JDP2 ZBTB41 ZNF395 CREB1 ATF6B CREM RXRA RXRB HOXA13 ZSCAN32 SOHLH2 SMARCA4 CCAR1 ZNF808 MAFB ATF1	7.12e-06	1271	95	19	GO:0000987
GeneOntologyMolecularFunction	lysine-acetylated histone binding	BRD3 BRD4 SMARCA4 TAF1	1.20e-05	30	95	4	GO:0070577
GeneOntologyMolecularFunction	acetylation-dependent protein binding	BRD3 BRD4 SMARCA4 TAF1	1.37e-05	31	95	4	GO:0140033
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZNF438 IKZF3 ZNF573 ZSCAN31 PEG3 JDP2 ZBTB41 ZNF395 CREB1 ATF6B CREM RXRA RXRB HOXA13 ZSCAN32 SOHLH2 ZNF808 MAFB ATF1	3.12e-05	1412	95	19	GO:0000981
GeneOntologyMolecularFunction	SNAP receptor activity	SEC22B STX1B STX18 STX7	3.48e-05	39	95	4	GO:0005484
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	TRIM15 ANK3 ATG2B SEC22B BRD3 JMJD1C RXRB STX1B STX18 CARD9 BRD4 RNF20 SMARCA2 SMARCA4 CCAR1 STX7	1.09e-04	1160	95	16	GO:0030674
GeneOntologyMolecularFunction	nuclear receptor binding	TACC2 JMJD1C RXRA RXRB SMARCA4 TAF1	2.71e-04	187	95	6	GO:0016922
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	IKZF3 ZNF395 CREB1 ATF6B RXRB HOXA13 SOHLH2 ZNF808 MAFB ATF1	3.31e-04	560	95	10	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	IKZF3 ZNF395 CREB1 ATF6B RXRB HOXA13 SOHLH2 ZNF808 MAFB ATF1	3.60e-04	566	95	10	GO:0001216
GeneOntologyMolecularFunction	retinoic acid-responsive element binding	RXRA RXRB	4.63e-04	7	95	2	GO:0044323
GeneOntologyMolecularFunction	p53 binding	BRD4 RNF20 SMARCA4 TAF1	4.99e-04	77	95	4	GO:0002039
GeneOntologyMolecularFunction	nuclear thyroid hormone receptor binding	JMJD1C RXRA RXRB	5.61e-04	34	95	3	GO:0046966
GeneOntologyMolecularFunction	transcription coactivator activity	TRIM15 RXRB BRD4 RNF20 SMARCA2 SMARCA4 CCAR1	6.11e-04	303	95	7	GO:0003713
GeneOntologyMolecularFunction	molecular adaptor activity	TRIM15 ANK3 ATG2B SEC22B BRD3 JMJD1C RXRB STX1B STX18 CARD9 BRD4 RNF20 SMARCA2 SMARCA4 CCAR1 STX7	6.28e-04	1356	95	16	GO:0060090
GeneOntologyMolecularFunction	chromatin binding	IKZF3 JDP2 BRD3 JMJD1C RXRA RXRB BRD4 RNF20 SMARCA2 SMARCA4 TAF1	7.66e-04	739	95	11	GO:0003682
GeneOntologyMolecularFunction	microfilament motor activity	MYO9A MYO3A MYO3B	7.80e-04	38	95	3	GO:0000146
GeneOntologyMolecularFunction	aspartic-type endopeptidase inhibitor activity	NLRP2 SORL1	7.89e-04	9	95	2	GO:0019828
GeneOntologyMolecularFunction	cAMP response element binding	JDP2 CREB1	1.43e-03	12	95	2	GO:0035497
GeneOntologyMolecularFunction	semaphorin receptor activity	PLXNA3 PLXNA1	1.43e-03	12	95	2	GO:0017154
GeneOntologyMolecularFunction	histone binding	BRD3 BRD4 RNF20 SMARCA2 SMARCA4 TAF1	1.67e-03	265	95	6	GO:0042393
GeneOntologyMolecularFunction	modification-dependent protein binding	ANK3 BRD3 BRD4 SMARCA4 TAF1	3.04e-03	206	95	5	GO:0140030
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	TCEA1 IKZF3 PEG3 BRD3 ZNF395 CREB1 ATF6B CREM RXRA RXRB HOXA13 NAMPT SOHLH2 BRD4 RNF20 SMARCA2 SMARCA4 ZNF808 MAFB ATF1 TAF1	1.28e-06	1390	96	21	GO:0045944
GeneOntologyBiologicalProcess	cranial nerve formation	PLXNA3 MAFB PLXNA1	1.57e-05	11	96	3	GO:0021603
GeneOntologyBiologicalProcess	olfactory nerve formation	PLXNA3 PLXNA1	2.14e-05	2	96	2	GO:0021628
GeneOntologyBiologicalProcess	olfactory nerve morphogenesis	PLXNA3 PLXNA1	6.41e-05	3	96	2	GO:0021627
GeneOntologyCellularComponent	ATF4-CREB1 transcription factor complex	CREB1 CREM ATF1	3.74e-07	4	96	3	GO:1990589
GeneOntologyCellularComponent	RNA polymerase II transcription regulator complex	TCEA1 JDP2 CREB1 ATF6B CREM RXRA RXRB MAFB ATF1 TAF1	4.97e-07	272	96	10	GO:0090575
GeneOntologyCellularComponent	SNARE complex	SEC22B STX1B STX18 STX7	8.85e-05	51	96	4	GO:0031201
GeneOntologyCellularComponent	chromatin	JDP2 BRD3 CREB1 ATF6B JMJD1C CREM RXRA RXRB HOXA13 SOHLH2 BRD4 RNF20 SMARCA2 SMARCA4 MTBP MAFB ATF1 TAF1	1.22e-04	1480	96	18	GO:0000785
GeneOntologyCellularComponent	transcription regulator complex	TCEA1 JDP2 CREB1 ATF6B CREM RXRA RXRB MAFB ATF1 TAF1	4.11e-04	596	96	10	GO:0005667
GeneOntologyCellularComponent	nuclear protein-containing complex	TCEA1 AFF3 JDP2 CREB1 ATF6B JMJD1C CREM RXRA RXRB BRD4 SMARCA2 SMARCA4 MAFB ATF1 TAF1 MX2	5.09e-04	1377	96	16	GO:0140513
GeneOntologyCellularComponent	bBAF complex	SMARCA2 SMARCA4	9.17e-04	10	96	2	GO:0140092
GeneOntologyCellularComponent	semaphorin receptor complex	PLXNA3 PLXNA1	1.58e-03	13	96	2	GO:0002116
GeneOntologyCellularComponent	nuclear envelope lumen	CCAR1 SORL1	1.83e-03	14	96	2	GO:0005641
GeneOntologyCellularComponent	npBAF complex	SMARCA2 SMARCA4	1.83e-03	14	96	2	GO:0071564
GeneOntologyCellularComponent	GBAF complex	SMARCA2 SMARCA4	1.83e-03	14	96	2	GO:0140288
HumanPheno	Abnormal tarsal ossification	PTH1R HOXA13 EIF2AK3	1.36e-05	9	29	3	HP:0008369
HumanPheno	Joint dislocation	MYO9A CEP85L AFF3 JMJD1C TGFB2 BRD4 GPC4 SMARCA2 MAFB EIF2AK3	3.29e-05	390	29	10	HP:0001373
HumanPheno	Abnormal hand bone ossification	PTH1R HOXA13 GPC4 MAFB EIF2AK3	3.90e-05	70	29	5	HP:0010660
Domain	KID	CREB1 CREM ATF1	1.32e-07	3	96	3	PS50953
Domain	Coactivator_CBP_pKID	CREB1 CREM ATF1	1.32e-07	3	96	3	IPR003102
Domain	pKID	CREB1 CREM ATF1	1.32e-07	3	96	3	PF02173
Domain	Bromodomain_CS	BRD3 BRD4 SMARCA2 SMARCA4 TAF1	1.95e-07	26	96	5	IPR018359
Domain	BRLZ	JDP2 CREB1 ATF6B CREM MAFB ATF1	2.65e-07	52	96	6	SM00338
Domain	BZIP	JDP2 CREB1 ATF6B CREM MAFB ATF1	2.97e-07	53	96	6	PS50217
Domain	BZIP_BASIC	JDP2 CREB1 ATF6B CREM MAFB ATF1	2.97e-07	53	96	6	PS00036
Domain	bZIP	JDP2 CREB1 ATF6B CREM MAFB ATF1	3.33e-07	54	96	6	IPR004827
Domain	Leuzip_CREB	CREB1 CREM ATF1	5.24e-07	4	96	3	IPR001630
Domain	bZIP_1	JDP2 CREB1 ATF6B CREM ATF1	7.99e-07	34	96	5	PF00170
Domain	BROMODOMAIN_1	BRD3 BRD4 SMARCA2 SMARCA4 TAF1	1.24e-06	37	96	5	PS00633
Domain	TF_DNA-bd	CREB1 ATF6B CREM MAFB ATF1	1.24e-06	37	96	5	IPR008917
Domain	Bromodomain	BRD3 BRD4 SMARCA2 SMARCA4 TAF1	1.42e-06	38	96	5	PF00439
Domain	BROMODOMAIN_2	BRD3 BRD4 SMARCA2 SMARCA4 TAF1	2.09e-06	41	96	5	PS50014
Domain	BROMO	BRD3 BRD4 SMARCA2 SMARCA4 TAF1	2.36e-06	42	96	5	SM00297
Domain	Bromodomain	BRD3 BRD4 SMARCA2 SMARCA4 TAF1	2.36e-06	42	96	5	IPR001487
Domain	-	BRD3 BRD4 SMARCA2 SMARCA4 TAF1	2.36e-06	42	96	5	1.20.920.10
Domain	SnAC	SMARCA2 SMARCA4	2.61e-05	2	96	2	SM01314
Domain	Gln-Leu-Gln_QLQ	SMARCA2 SMARCA4	2.61e-05	2	96	2	IPR014978
Domain	SnAC	SMARCA2 SMARCA4	2.61e-05	2	96	2	IPR029295
Domain	SnAC	SMARCA2 SMARCA4	2.61e-05	2	96	2	PF14619
Domain	QLQ	SMARCA2 SMARCA4	2.61e-05	2	96	2	SM00951
Domain	QLQ	SMARCA2 SMARCA4	2.61e-05	2	96	2	PS51666
Domain	QLQ	SMARCA2 SMARCA4	2.61e-05	2	96	2	PF08880
Domain	Syntaxin/epimorphin_CS	STX1B STX18 STX7	7.02e-05	16	96	3	IPR006012
Domain	SYNTAXIN	STX1B STX18 STX7	7.02e-05	16	96	3	PS00914
Domain	HSA	SMARCA2 SMARCA4	1.56e-04	4	96	2	SM00573
Domain	BET	BRD3 BRD4	1.56e-04	4	96	2	PF17035
Domain	NET_dom	BRD3 BRD4	1.56e-04	4	96	2	IPR027353
Domain	HSA	SMARCA2 SMARCA4	1.56e-04	4	96	2	PS51204
Domain	HSA_dom	SMARCA2 SMARCA4	1.56e-04	4	96	2	IPR014012
Domain	HSA	SMARCA2 SMARCA4	1.56e-04	4	96	2	PF07529
Domain	NET	BRD3 BRD4	1.56e-04	4	96	2	PS51525
Domain	T_SNARE	STX1B STX18 STX7	3.14e-04	26	96	3	PS50192
Domain	BRK	SMARCA2 SMARCA4	3.87e-04	6	96	2	SM00592
Domain	BRK_domain	SMARCA2 SMARCA4	3.87e-04	6	96	2	IPR006576
Domain	BRK	SMARCA2 SMARCA4	3.87e-04	6	96	2	PF07533
Domain	T_SNARE_dom	STX1B STX18 STX7	4.36e-04	29	96	3	IPR000727
Domain	Plexin_cytopl	PLXNA3 PLXNA1	9.19e-04	9	96	2	PF08337
Domain	ZU5	ANK3 UNC5D	9.19e-04	9	96	2	SM00218
Domain	Plexin_cytoplasmic_RasGAP_dom	PLXNA3 PLXNA1	9.19e-04	9	96	2	IPR013548
Domain	SynN	STX1B STX7	9.19e-04	9	96	2	SM00503
Domain	Plexin	PLXNA3 PLXNA1	9.19e-04	9	96	2	IPR031148
Domain	Myosin_head_motor_dom	MYO9A MYO3A MYO3B	9.74e-04	38	96	3	IPR001609
Domain	MYOSIN_MOTOR	MYO9A MYO3A MYO3B	9.74e-04	38	96	3	PS51456
Domain	Myosin_head	MYO9A MYO3A MYO3B	9.74e-04	38	96	3	PF00063
Domain	MYSc	MYO9A MYO3A MYO3B	9.74e-04	38	96	3	SM00242
Domain	Retinoid-X_rcpt/HNF4	RXRA RXRB	1.15e-03	10	96	2	IPR000003
Domain	ZU5	ANK3 UNC5D	1.15e-03	10	96	2	PS51145
Domain	-	ANK3 NLRP2 CARD9 UNC5D	1.35e-03	93	96	4	1.10.533.10
Domain	Syntaxin	STX1B STX7	1.40e-03	11	96	2	PF00804
Domain	t-SNARE	STX1B STX18 STX7	1.40e-03	43	96	3	IPR010989
Domain	ZU5	ANK3 UNC5D	1.67e-03	12	96	2	PF00791
Domain	Syntaxin_N	STX1B STX7	1.67e-03	12	96	2	IPR006011
Domain	ZU5_dom	ANK3 UNC5D	1.67e-03	12	96	2	IPR000906
Domain	DEATH-like_dom	ANK3 NLRP2 CARD9 UNC5D	1.70e-03	99	96	4	IPR011029
Domain	SCAN	ZSCAN31 PEG3 ZSCAN32	3.00e-03	56	96	3	SM00431
Domain	SCAN_BOX	ZSCAN31 PEG3 ZSCAN32	3.31e-03	58	96	3	PS50804
Domain	SCAN	ZSCAN31 PEG3 ZSCAN32	3.31e-03	58	96	3	PF02023
Domain	SCAN_dom	ZSCAN31 PEG3 ZSCAN32	3.31e-03	58	96	3	IPR003309
Domain	Retrov_capsid_C	ZSCAN31 PEG3 ZSCAN32	3.47e-03	59	96	3	IPR008916
Pathway	WP_VITAMIN_D_METABOLISM	GC RXRA RXRB	1.10e-05	10	65	3	M39352
Pathway	KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT	SEC22B STX1B STX18 STX7	2.70e-05	38	65	4	M17857
Pathway	REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION	PLXNA3 PAK3 PLXNA1	3.28e-05	14	65	3	MM15029
Pathway	REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION	PLXNA3 PAK3 PLXNA1	5.02e-05	16	65	3	M16498
Pathway	REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE	RXRA RXRB	2.07e-04	5	65	2	M29791
Pathway	REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE	RXRA RXRB	2.07e-04	5	65	2	M29792
Pathway	KEGG_MEDICUS_VARIANT_PAX8_PPARG_FUSION_TO_PPARG_MEDIATED_TRANSCRIPTION	RXRA RXRB	2.07e-04	5	65	2	M49023
Pathway	REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS	RXRA RXRB	2.07e-04	5	65	2	M29812
Pathway	REACTOME_CIRCADIAN_CLOCK	CREB1 CREM RXRA NAMPT	3.00e-04	70	65	4	M938
Pathway	WP_VITAMIN_A1_AND_A5X_PATHWAYS	RXRA RXRB	3.10e-04	6	65	2	M48097
Pathway	REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS	RXRA RXRB	3.10e-04	6	65	2	MM15663
Pathway	WP_KLEEFSTRA_SYNDROME	RXRA SMARCA2 SMARCA4	3.14e-04	29	65	3	M48076
Pathway	REACTOME_CREB_PHOSPHORYLATION	CREB1 ATF1	4.33e-04	7	65	2	M27096
Pathway	REACTOME_CREB_PHOSPHORYLATION	CREB1 ATF1	4.33e-04	7	65	2	MM14784
Pathway	REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION	PLXNA3 PLXNA1	7.38e-04	9	65	2	MM15030
Pathway	REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS	RXRA RXRB	7.38e-04	9	65	2	M29789
Pathway	KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY	RXRA RXRB	7.38e-04	9	65	2	M47629
Pathway	REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS	RXRA RXRB	7.38e-04	9	65	2	M29809
Pathway	REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION	CREB1 SMARCA2 SMARCA4	9.45e-04	42	65	3	M48237
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZNF438 TCEA1 PLXNA3 PEG3 ZBTB41 BRD3 ATF6B CREM RXRA RXRB SOHLH2 BRD4 SMARCA2 CCAR1 ATF1 PLXNA1	8.56e-10	808	97	16	20412781
Pubmed	Secalonic acid D alters the expression and phosphorylation of the transcription factors and their binding to cAMP response element in developing murine secondary palate.	CREB1 CREM ATF1	8.40e-08	4	97	3	11354513
Pubmed	EWSR1 Fusions With CREB Family Transcription Factors Define a Novel Myxoid Mesenchymal Tumor With Predilection for Intracranial Location.	CREB1 CREM ATF1	8.40e-08	4	97	3	28009602
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	TCEA1 PLXNA3 PEG3 BRD3 TACC2 CREM RXRA RXRB HOXA13 BRD4 SMARCA2 SMARCA4 PLXNA1	9.13e-08	709	97	13	22988430
Pubmed	Disruption of CREB function in brain leads to neurodegeneration.	CREB1 CREM ATF1	2.09e-07	5	97	3	11967539
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TCEA1 RBBP6 BRD3 CCNY MYO3A NOL4L BRD4 RNF20 SMARCA2 SMARCA4 CCAR1 PLEC UNC5D	2.49e-07	774	97	13	15302935
Pubmed	Activating transcription factor 1 and CREB are important for cell survival during early mouse development.	CREB1 CREM ATF1	4.18e-07	6	97	3	11865068
Pubmed	Activation of ATP-binding cassette transporter A1 transcription by chromatin remodeling complex.	RXRA SMARCA2 SMARCA4	4.18e-07	6	97	3	15774904
Pubmed	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	ADAMTSL1 RBBP6 JDP2 TACC2 LGSN ZNF804A CCDC27 MYO3A CARD9 MYO3B MAFB ADGRL2 PCDH18	4.39e-07	814	97	13	23251661
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	CREB1 JMJD1C PRR12 BRD4 RNF20 SMARCA2 SMARCA4 TAF1	8.95e-07	268	97	8	33640491
Pubmed	Specific ablation of the transcription factor CREB in sympathetic neurons surprisingly protects against developmentally regulated apoptosis.	CREB1 CREM ATF1	1.17e-06	8	97	3	17376811
Pubmed	Protein kinase A signalling via CREB controls myogenesis induced by Wnt proteins.	CREB1 CREM ATF1	1.75e-06	9	97	3	15568017
Pubmed	Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB.	CREB1 CREM ATF1	1.75e-06	9	97	3	11988169
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	BRD3 BRD4 SMARCA2 SMARCA4 TAF1	2.25e-06	75	97	5	25593309
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	TCEA1 RBBP6 CREB1 JMJD1C CREM HOXA13 SLC35F3 BRD4 SMARCA4 CCAR1 ZNF808 ATF1 TAF1	2.55e-06	954	97	13	36373674
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ATXN7L2 RBBP6 JDP2 SEC22B BRD3 ZNF395 CREB1 JMJD1C CREM PRR12 BRD4 RNF20 SMARCA4 CCAR1 ATF1	2.96e-06	1294	97	15	30804502
Pubmed	Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes.	IKZF3 SMARCA2 SMARCA4	3.41e-06	11	97	3	10204490
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	TCEA1 RBBP6 BRD3 RXRA NAMPT BRD4 RNF20 SMARCA2 SMARCA4 CCAR1 ATF1 TAF1 PLEC	4.94e-06	1014	97	13	32416067
Pubmed	The transcription factor Mesp1 interacts with cAMP-responsive element binding protein 1 (Creb1) and coactivates Ets variant 2 (Etv2) gene expression.	CREB1 CREM ATF1	5.89e-06	13	97	3	25694434
Pubmed	Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.	GC RXRA RXRB	5.89e-06	13	97	3	19255064
Pubmed	The expanding family of CREB/CREM transcription factors that are involved with spermatogenesis.	CREB1 CREM	7.70e-06	2	97	2	11988318
Pubmed	RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis.	RXRA RXRB	7.70e-06	2	97	2	7926783
Pubmed	Mouse class III myosins: kinase activity and phosphorylation sites.	MYO3A MYO3B	7.70e-06	2	97	2	21895655
Pubmed	The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis.	SMARCA2 SMARCA4	7.70e-06	2	97	2	8670841
Pubmed	Neurogenic transdifferentiation of human adipose-derived stem cells? A critical protocol reevaluation with special emphasis on cell proliferation and cell cycle alterations.	CREB1 ATF1	7.70e-06	2	97	2	20945072
Pubmed	Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features.	SMARCA2 SMARCA4	7.70e-06	2	97	2	23163725
Pubmed	CREB function is required for normal thymic cellularity and post-irradiation recovery.	CREB1 ATF1	7.70e-06	2	97	2	15214044
Pubmed	Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development.	SMARCA2 SMARCA4	7.70e-06	2	97	2	23076393
Pubmed	Increased hippocampal neurogenesis and accelerated response to antidepressants in mice with specific deletion of CREB in the hippocampus: role of cAMP response-element modulator τ.	CREB1 CREM	7.70e-06	2	97	2	23966689
Pubmed	Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory.	CREB1 ATF1	7.70e-06	2	97	2	11988175
Pubmed	Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein.	SMARCA2 SMARCA4	7.70e-06	2	97	2	9603422
Pubmed	The SWI/SNF chromatin remodeling protein Brg1 is required for vertebrate neurogenesis and mediates transactivation of Ngn and NeuroD.	SMARCA2 SMARCA4	7.70e-06	2	97	2	15576411
Pubmed	The role of cAMP response element-binding protein in estrogen negative feedback control of gonadotropin-releasing hormone neurons.	CREB1 CREM	7.70e-06	2	97	2	22895714
Pubmed	SWI/SNF gene variants and glioma risk and outcome.	SMARCA2 SMARCA4	7.70e-06	2	97	2	23276717
Pubmed	Differential Expression of SWI/SNF Chromatin Remodeler Subunits Brahma and Brahma-Related Gene During Drug-Induced Liver Injury and Regeneration in Mouse Model.	SMARCA2 SMARCA4	7.70e-06	2	97	2	27097303
Pubmed	Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.	SMARCA2 SMARCA4	7.70e-06	2	97	2	15240517
Pubmed	Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.	SMARCA2 SMARCA4	7.70e-06	2	97	2	26564006
Pubmed	SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction.	SMARCA2 SMARCA4	7.70e-06	2	97	2	33027072
Pubmed	SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens.	SMARCA2 SMARCA4	7.70e-06	2	97	2	28038711
Pubmed	cAMP response element-binding protein regulates differentiation and survival of newborn neurons in the olfactory bulb.	CREB1 CREM	7.70e-06	2	97	2	16267218
Pubmed	A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.	SMARCA2 SMARCA4	7.70e-06	2	97	2	23872584
Pubmed	Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury.	SMARCA2 SMARCA4	7.70e-06	2	97	2	23963727
Pubmed	Retinoid-X-receptors (α/β) in melanocytes modulate innate immune responses and differentially regulate cell survival following UV irradiation.	RXRA RXRB	7.70e-06	2	97	2	24810760
Pubmed	Cyclic adenosine 5'-monophosphate response element binding protein plays a central role in mediating proliferation and differentiation downstream of the pre-TCR complex in developing thymocytes.	CREB1 CREM	7.70e-06	2	97	2	15265911
Pubmed	SW13 cells can transition between two distinct subtypes by switching expression of BRG1 and Brm genes at the post-transcriptional level.	SMARCA2 SMARCA4	7.70e-06	2	97	2	12493776
Pubmed	Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4.	SMARCA2 SMARCA4	7.70e-06	2	97	2	31375262
Pubmed	Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.	SMARCA2 SMARCA4	7.70e-06	2	97	2	23088494
Pubmed	Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.	SMARCA2 SMARCA4	7.70e-06	2	97	2	17075831
Pubmed	Limited degradation of retinoid X receptor by calpain.	RXRA RXRB	7.70e-06	2	97	2	8780715
Pubmed	SWI/SNF chromatin remodeling enzyme ATPases promote cell proliferation in normal mammary epithelial cells.	SMARCA2 SMARCA4	7.70e-06	2	97	2	20333683
Pubmed	Cyclic AMP response element-binding protein is required for normal maternal nurturing behavior.	CREB1 CREM	7.70e-06	2	97	2	15893884
Pubmed	SWI/SNF Complex-deficient Undifferentiated Carcinoma of the Gastrointestinal Tract: Clinicopathologic Study of 30 Cases With an Emphasis on Variable Morphology, Immune Features, and the Prognostic Significance of Different SMARCA4 and SMARCA2 Subunit Deficiencies.	SMARCA2 SMARCA4	7.70e-06	2	97	2	34812766
Pubmed	Nuclear hormone retinoid X receptor (RXR) negatively regulates the glucose-stimulated insulin secretion of pancreatic ß-cells.	RXRA RXRB	7.70e-06	2	97	2	20798333
Pubmed	Dysfunction of the RAR/RXR signaling pathway in the forebrain impairs hippocampal memory and synaptic plasticity.	RXRA RXRB	7.70e-06	2	97	2	22316320
Pubmed	Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma.	SMARCA2 SMARCA4	7.70e-06	2	97	2	32855269
Pubmed	Abnormal long-lasting synaptic plasticity and cognition in mice lacking the mental retardation gene Pak3.	CREB1 PAK3	7.70e-06	2	97	2	16014725
Pubmed	Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy.	SMARCA2 SMARCA4	7.70e-06	2	97	2	30478150
Pubmed	Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity.	SMARCA2 SMARCA4	7.70e-06	2	97	2	22721696
Pubmed	Targeting of the CREB gene leads to up-regulation of a novel CREB mRNA isoform.	CREB1 CREM	7.70e-06	2	97	2	8605879
Pubmed	Genetic variant of RXR involved in the vitamin D metabolic pathway was linked to HCV infection outcomes among a high-risk Chinese population.	RXRA RXRB	7.70e-06	2	97	2	33246082
Pubmed	BRD3 and BRD4 BET Bromodomain Proteins Differentially Regulate Skeletal Myogenesis.	BRD3 BRD4	7.70e-06	2	97	2	28733670
Pubmed	Endogenous retinoid X receptor ligands in mouse hematopoietic cells.	RXRA RXRB	7.70e-06	2	97	2	29089448
Pubmed	Chromatin remodeling complexes interact dynamically with a glucocorticoid receptor-regulated promoter.	SMARCA2 SMARCA4	7.70e-06	2	97	2	18508913
Pubmed	Epistatic interaction of CREB1 and KCNJ6 on rumination and negative emotionality.	CREB1 KCNJ6	7.70e-06	2	97	2	20943350
Pubmed	Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling.	SMARCA2 SMARCA4	7.70e-06	2	97	2	11719516
Pubmed	The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation.	SMARCA2 SMARCA4	7.70e-06	2	97	2	25808524
Pubmed	Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation.	SMARCA2 SMARCA4	7.70e-06	2	97	2	19144648
Pubmed	DNA binding drives the association of BRG1/hBRM bromodomains with nucleosomes.	SMARCA2 SMARCA4	7.70e-06	2	97	2	28706277
Pubmed	Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT/enhancer-binding protein (C/EBP) alpha, C/EBP beta, or PPAR gamma 2.	CREB1 ATF1	7.70e-06	2	97	2	17071615
Pubmed	Three retinoid X receptor gene polymorphisms in plaque psoriasis and psoriasis guttata.	RXRA RXRB	7.70e-06	2	97	2	17341859
Pubmed	Impact of the Motor and Tail Domains of Class III Myosins on Regulating the Formation and Elongation of Actin Protrusions.	MYO3A MYO3B	7.70e-06	2	97	2	27582493
Pubmed	[Expression of BRG1 and BRM proteins in prostatic cancer].	SMARCA2 SMARCA4	7.70e-06	2	97	2	21092585
Pubmed	CREB is activated by ER stress and modulates the unfolded protein response by regulating the expression of IRE1α and PERK.	CREB1 EIF2AK3	7.70e-06	2	97	2	26642955
Pubmed	High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.	SMARCA2 SMARCA4	7.70e-06	2	97	2	29391527
Pubmed	Association of increased genotypes risk for bipolar disorder with brain white matter integrity investigated with tract-based spatial statistics: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summarise relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.	ANK3 ZNF804A	7.70e-06	2	97	2	28648753
Pubmed	ANK3 rs10994336 and ZNF804A rs7597593 polymorphisms: genetic interaction for emotional and behavioral symptoms of alcohol withdrawal syndrome.	ANK3 ZNF804A	7.70e-06	2	97	2	38702695
Pubmed	Expression of SMARCA2 and SMARCA4 in gastric adenocarcinoma and construction of a nomogram prognostic model.	SMARCA2 SMARCA4	7.70e-06	2	97	2	37634210
Pubmed	SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.	SMARCA2 SMARCA4	7.70e-06	2	97	2	26551623
Pubmed	Impaired expression of the inducible cAMP early repressor accounts for sustained adipose CREB activity in obesity.	CREB1 CREM	7.70e-06	2	97	2	21998402
Pubmed	Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin.	RXRA RXRB	7.70e-06	2	97	2	16199515
Pubmed	Cell-specific occupancy of an extended repertoire of CREM and CREB binding loci in male germ cells.	CREB1 CREM	7.70e-06	2	97	2	20920259
Pubmed	SWI/SNF deficiency results in aberrant chromatin organization, mitotic failure, and diminished proliferative capacity.	SMARCA2 SMARCA4	7.70e-06	2	97	2	19458193
Pubmed	Transgenic mice lacking CREB and CREM in noradrenergic and serotonergic neurons respond differently to common antidepressants on tail suspension test.	CREB1 CREM	7.70e-06	2	97	2	29044198
Pubmed	Recruitment of Brd3 and Brd4 to acetylated chromatin is essential for proinflammatory cytokine-induced matrix-degrading enzyme expression.	BRD3 BRD4	7.70e-06	2	97	2	30786900
Pubmed	Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor.	SMARCA2 SMARCA4	7.70e-06	2	97	2	8208605
Pubmed	The Bromodomains of the mammalian SWI/SNF (mSWI/SNF) ATPases Brahma (BRM) and Brahma Related Gene 1 (BRG1) promote chromatin interaction and are critical for skeletal muscle differentiation.	SMARCA2 SMARCA4	7.70e-06	2	97	2	34289068
Pubmed	BRD3/4 inhibition and FLT3-ligand deprivation target pathways that are essential for the survival of human MLL-AF9+ leukemic cells.	BRD3 BRD4	7.70e-06	2	97	2	29240787
Pubmed	SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria.	SMARCA2 SMARCA4	7.70e-06	2	97	2	34518526
Pubmed	SMARCA family of genes.	SMARCA2 SMARCA4	7.70e-06	2	97	2	32312722
Pubmed	Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.	SMARCA2 SMARCA4	7.70e-06	2	97	2	26356327
Pubmed	An isoform of transcription factor CREM expressed during spermatogenesis lacks the phosphorylation domain and represses cAMP-induced transcription.	CREB1 CREM	7.70e-06	2	97	2	7809053
Pubmed	A transcriptionally silent RXRalpha supports early embryonic morphogenesis and heart development.	RXRA RXRB	7.70e-06	2	97	2	19255444
Pubmed	Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.	SMARCA2 SMARCA4	7.70e-06	2	97	2	12566296
Pubmed	A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes.	SMARCA2 SMARCA4	7.70e-06	2	97	2	11163203
Pubmed	Identification of human myometrial target genes of the cAMP pathway: the role of cAMP-response element binding (CREB) and modulator (CREMalpha and CREMtau2alpha) proteins.	CREB1 CREM	7.70e-06	2	97	2	15691874
Pubmed	Human CREM gene: evolutionary conservation, chromosomal localization, and inducibility of the transcript.	CREB1 CREM	7.70e-06	2	97	2	7916662
Pubmed	Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes.	SMARCA2 SMARCA4	7.70e-06	2	97	2	12620226
Pubmed	Cyclic AMP response element binding protein CREB and modulator protein CREM are products of distinct genes.	CREB1 CREM	7.70e-06	2	97	2	1461747
Pubmed	SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines.	SMARCA2 SMARCA4	7.70e-06	2	97	2	31406271
Pubmed	BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivo.	SMARCA2 SMARCA4	7.70e-06	2	97	2	27039070
Interaction	NR4A2 interactions	CREB1 RXRA RXRB SMARCA2 SMARCA4	1.64e-07	27	96	5	int:NR4A2
Interaction	TAF11 interactions	TCEA1 BRD3 RXRA RXRB TAF1	4.36e-06	51	96	5	int:TAF11
Cytoband	4p15.32	FAM200B FGFBP1	5.20e-04	16	97	2	4p15.32
Cytoband	10p11.21	CREM CCNY	7.38e-04	19	97	2	10p11.21
Cytoband	Ensembl 112 genes in cytogenetic band chr10q21	ANK3 JMJD1C CCAR1	2.05e-03	118	97	3	chr10q21
Cytoband	10q21.3	JMJD1C CCAR1	2.37e-03	34	97	2	10q21.3
Cytoband	Ensembl 112 genes in cytogenetic band chr10p11	ZNF438 CREM CCNY	2.52e-03	127	97	3	chr10p11
GeneFamily	Basic leucine zipper proteins	JDP2 CREB1 ATF6B CREM MAFB ATF1	2.11e-08	49	65	6	506
GeneFamily	Myosins, class III\|Deafness associated genes	MYO3A MYO3B	1.27e-05	2	65	2	1099
GeneFamily	Syntaxins	STX1B STX18 STX7	2.40e-05	16	65	3	818
GeneFamily	Plexins	PLXNA3 PLXNA1	4.51e-04	9	65	2	683
GeneFamily	Non-clustered protocadherins	PCDH17 PCDH18	8.21e-04	12	65	2	21
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF438 IKZF3 ZNF573 ZSCAN31 PEG3 ZBTB41 ZNF395 ZSCAN32 ZNF808	1.02e-03	718	65	9	28
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#3_top-relative-expression-ranked_500	ADAMTSL1 RBBP6 PEG3 AFF3 TGFB2 ADGRL2 PCDH18	2.18e-05	188	95	7	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500_k3
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_k-means-cluster#5_top-relative-expression-ranked_1000	ADAMTSL1 RBBP6 PEG3 AFF3 TGFB2 SMARCA2 ADGRL2 PCDH18	4.55e-05	288	95	8	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000_k5
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4	IL13RA1 ADAMTSL1 BEND5 PEG3 AFF3 SLC22A15 JDP2 PTH1R STX1B TGFB2 SMARCA2 PAK3 PRR14L UPP2 PCDH18 SORL1	4.67e-05	1148	95	16	facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_100	PEG3 AFF3 PCDH18	7.98e-05	19	95	3	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_100
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IKZF3 JMJD1C CREM NAMPT MX2 SORL1	2.85e-06	181	97	6	71e55acd1d8e4307e56534c74a50e7be4d1dda0d
ToppCell	PBMC-Severe-cDC_5\|Severe / Compartment, Disease Groups and Clusters	JDP2 JMJD1C CREM CCNY NAMPT RASGEF1B	4.24e-06	194	97	6	b903e23eb75733ca516770727097fe74a9f8c1d1
ToppCell	Control-Classical_Monocyte-cMono_2\|Control / Disease condition and Cell class	IL13RA1 JMJD1C RXRA CCNY NAMPT SORL1	4.37e-06	195	97	6	0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	JMJD1C CREM NAMPT RASGEF1B MAFB EIF2AK3	4.50e-06	196	97	6	01cea0bb0b938d0986fd2ddae06597b8af1768ee
ToppCell	PBMC-Mild-cDC_0\|Mild / Compartment, Disease Groups and Clusters	SLC22A15 JDP2 ZNF395 RXRA MAFB SORL1	4.77e-06	198	97	6	fb873b7636bb1c7b119dd5b23d7a20f518e6c6da
ToppCell	severe-HLA-DR+_CD83+_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	JMJD1C RXRA NAMPT RASGEF1B MAFB SORL1	4.77e-06	198	97	6	d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b
ToppCell	Mild/Remission-B_intermediate-0\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	IKZF3 ANK3 AFF3 SLC22A15 ZNF395 ZNF804A	4.91e-06	199	97	6	592111591f0f6816fc56620cb555eb48dabf0758
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	ANK3 AFF3 SLC35F3 PAK3 ADGRL2 UNC5D	5.05e-06	200	97	6	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	Influenza\|World / Disease, condition lineage and cell class	JDP2 RXRA CCNY NAMPT MAFB PLEC	5.05e-06	200	97	6	df996c35907a1c9194b9e2ca30e81f520ca067f0
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	IL13RA1 PCDH17 GPC4 NXPH2 MX2	1.39e-05	140	97	5	2c44e8cc5190226049be7ebc465d685393e701c4
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCDC146 ACSM4 TTLL6 ABCC12 ODAD3	2.00e-05	151	97	5	e335dad89e0a44cdd302b9653154ba5d1ee5fe1a
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCDC146 ACSM4 TTLL6 ABCC12 ODAD3	2.00e-05	151	97	5	633ed52dd3b4cf1e87432cf0a1ca187d7b204e83
ToppCell	droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ATXN7L2 WDR93 CARD9 MX2 SORL1	3.15e-05	166	97	5	de319c960b0cd90b294f677d1ea1b013a2ce2d53
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HTR2B JDP2 CREM RASGEF1B MAFB	3.74e-05	172	97	5	53dbfe1ac658fd94370cf8e745048cb67fda1daf
ToppCell	mild_COVID-19_(asymptomatic)-B_memory\|World / disease group, cell group and cell class (v2)	ANK3 BEND5 AFF3 KCNJ6 GRAMD1C	4.28e-05	177	97	5	057871e211c6508b2a679d391f3cf0ac7ccfc628
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	JDP2 RXRA RASGEF1B MAFB MX2	4.64e-05	180	97	5	6f8fa9fa91cd25b92584972bb34d90c483222f52
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-Pericyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTSL1 PTH1R TGFB2 CARD9 GPC4	5.02e-05	183	97	5	0e8fb371d8eac777451c76f41d53577f5dfb740d
ToppCell	facs-Lung-EPCAM-24m-Mesenchymal-pericyte_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTSL1 PTH1R TGFB2 CARD9 GPC4	5.02e-05	183	97	5	cbc3b00faa7e4e0dbbbc8ee105467c65241c7470
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	JMJD1C CREM NAMPT RASGEF1B MAFB	5.15e-05	184	97	5	b45b1fdba13c8ed2a04a4fb3b62d8ad92785c768
ToppCell	facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell-pericyte\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PTH1R TGFB2 CARD9 GPC4 PCDH18	5.28e-05	185	97	5	a6cd90f8f30c7bdf66958cf403e73c193aa32f5e
ToppCell	facs-Lung-24m-Mesenchymal-myofibroblast-pericyte_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PTH1R TGFB2 CARD9 GPC4 PCDH18	5.28e-05	185	97	5	5053f932e2adfcf4d6faaecff2999ac53d8d7aa5
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 PEG3 TGFB2 GPC4 PAK3	5.28e-05	185	97	5	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	JMJD1C RXRA MAFB PLEC UNC5D	5.42e-05	186	97	5	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	Control-Endothelial-Endothelial-Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CEP85L AFF3 PCDH17 SMARCA2 ADGRL2	5.56e-05	187	97	5	ea9d34bcd3bd1f36745846309ede349773de501a
ToppCell	facs-Pancreas-Endocrine-3m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PEG3 GC GPC4 PAK3 MAFB	5.70e-05	188	97	5	e99e3765b48392c987cf0c5ccbded0655637d7b7
ToppCell	COPD-Lymphoid-B\|Lymphoid / Disease state, Lineage and Cell class	IL13RA1 AFF3 RASGEF1B GRAMD1C EIF2AK3	5.99e-05	190	97	5	1e85ee686ff6dd27c69415d524d54fa825b1daad
ToppCell	facs-Thymus-Epithelium-24m-Epithelial\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PEG3 GC WDR93 PAK3 MAFB	6.15e-05	191	97	5	eec14997d2bfc7e6b5a601afc43a147f6b96d668
ToppCell	facs-Thymus-Epithelium-24m-Epithelial-TECs\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PEG3 GC WDR93 PAK3 MAFB	6.15e-05	191	97	5	1730ec5dc1cfd2f0cba7e21555641c7bce97e09d
ToppCell	facs-Pancreas-Endocrine-3m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PEG3 GC GPC4 PAK3 MAFB	6.15e-05	191	97	5	b3de0393d6510543533cd851e47a0f95739a0e4e
ToppCell	facs-Thymus-Epithelium-24m-Epithelial-epithelial_cell_of_thymus\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PEG3 GC WDR93 PAK3 MAFB	6.15e-05	191	97	5	4b77abc68bd72c64e7062f9527fe9d9605289ceb
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IL13RA1 JDP2 RXRA NAMPT MAFB	6.30e-05	192	97	5	f14ee74ac3275601749a23c5efe39c2413a62e1a
ToppCell	PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IL13RA1 JDP2 RXRA NAMPT MAFB	6.30e-05	192	97	5	0219093e7921a0db78053aee13ec480b520f5662
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADAMTSL1 PEG3 WNT9A GRAMD1C PCDH18	6.46e-05	193	97	5	64edc1d6fb0fe117767d494cf4a5723bf8be2804
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CEP85L AFF3 PCDH17 SMARCA2 ADGRL2	6.46e-05	193	97	5	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	JDP2 RXRA NAMPT MAFB PLEC	6.46e-05	193	97	5	1db487e5f81849740d57cc3e2b5739e8f7581efb
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CEP85L AFF3 PCDH17 SMARCA2 ADGRL2	6.46e-05	193	97	5	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	368C-Lymphocytic-B_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TCEA1 IL13RA1 AFF3 RASGEF1B STX7	6.61e-05	194	97	5	9a72b6a3217b100617f468aaad48566a04334f3c
ToppCell	368C-Lymphocytic-B_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TCEA1 IL13RA1 AFF3 RASGEF1B STX7	6.61e-05	194	97	5	f8c46c5855a684ed5cb5289da4c29cf3e6052b97
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	AFF3 JMJD1C RASGEF1B STX7 EIF2AK3	6.61e-05	194	97	5	ff661419b697aef51a53fdeac8d37d870d65f491
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	JDP2 CREM NAMPT RASGEF1B MAFB	6.61e-05	194	97	5	449ce4167d64c170d914e0250f739eabedcf915d
ToppCell	facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	HTR2B AFF3 SMARCA2 ADGRL2 PLXNA1	6.78e-05	195	97	5	7e0ef92059ff34e368d2324815f49b50e3ca7332
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	AFF3 SLC35F3 PAK3 ADGRL2 UNC5D	6.94e-05	196	97	5	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	control-Myeloid-Non-resident_Macrophage\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	JMJD1C RXRA NAMPT MAFB SORL1	7.11e-05	197	97	5	df2fe36cb96e2565a9d21c24cb4e451e8befd4be
ToppCell	P03-Mesenchymal-myocytic_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	IL13RA1 WNT9A PTH1R TGFB2 GPC4	7.11e-05	197	97	5	079db904a08743b3c555cb7b3f5fb5c978dde25a
ToppCell	COVID-19_Severe-Non-classical_Monocyte\|World / disease group, cell group and cell class	JDP2 RXRA NAMPT RASGEF1B MAFB	7.11e-05	197	97	5	60fee75b12451206bb2c07b61651a73c59ec6ade
ToppCell	3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	JMJD1C CREM NAMPT MAFB MX2	7.11e-05	197	97	5	0c059476a8cdc6ac71a01d9c414295177f45f8de
ToppCell	mild_COVID-19-Classical_Monocyte\|World / disease group, cell group and cell class (v2)	IL13RA1 RXRA NAMPT RASGEF1B MAFB	7.11e-05	197	97	5	5d826f4d7b7a46847c67e6bef38eb860bc808a6c
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	JDP2 RXRA PCDH17 NAMPT MAFB	7.11e-05	197	97	5	7870c0651caefb0ed13d9f9dab43b5f24d6a9efc
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	JDP2 RXRA NAMPT RASGEF1B MAFB	7.28e-05	198	97	5	06201b34d3e38f22c93b759511f7b376504bac06
ToppCell	background-Hepatic_Stellate_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ADAMTSL1 ANK3 GC PTH1R RASGEF1B	7.28e-05	198	97	5	79f32f965aed6a10c5cb803173e3db7b32e07a91
ToppCell	mild_COVID-19-Classical_Monocyte\|mild_COVID-19 / disease group, cell group and cell class (v2)	IL13RA1 JDP2 RXRA NAMPT MAFB	7.28e-05	198	97	5	5b31b6e008e05d6528656114fbe0ccae8ffe13b1
ToppCell	PBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	JDP2 RXRA NAMPT RASGEF1B MAFB	7.28e-05	198	97	5	1ca91559fef231896e16180f5e050155c38f7cfa
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANK3 PEG3 AFF3 PAK3 ADGRL2	7.28e-05	198	97	5	0ff30edfd3c133a42e8cb96e1631a1143215f808
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RBBP6 RXRA NAMPT RASGEF1B MAFB	7.46e-05	199	97	5	5b6feacb0ca92c3fc6b327be978320426dcf6f68
ToppCell	control-CD163+_Monocytes_(Sample_ID1_d7)\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	IL13RA1 RXRA NAMPT MAFB MX2	7.46e-05	199	97	5	933201d32eda12a89660bdbae9114a95cc428a38
ToppCell	Control_saline\|World / Treatment groups by lineage, cell group, cell type	ZSCAN31 PCDH17 TGFB2 PLEC ADGRL2	7.46e-05	199	97	5	11c9c1779caceb725ecccf3f23b7d4e6dbd1af64
ToppCell	3'_v3-blood-Myeloid_Monocytic\|blood / Manually curated celltypes from each tissue	IL13RA1 JDP2 RXRA NAMPT MAFB	7.46e-05	199	97	5	bf3a5085a5ae50f2ef745dce0a4ca8833b9438fd
ToppCell	control-HLA-DR+_CD83+_Monocyte\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	IL13RA1 RXRA NAMPT RASGEF1B MAFB	7.46e-05	199	97	5	f1b370d2869ad29c9d8ff41fdcc486fffa781ee2
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ANK3 PTH1R TGFB2 GPC4 PCDH18	7.46e-05	199	97	5	6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c
ToppCell	3'_v3-blood-Myeloid_Monocytic-Classical_monocytes\|blood / Manually curated celltypes from each tissue	IL13RA1 JDP2 RXRA NAMPT MAFB	7.46e-05	199	97	5	95b27f4bf1300f885b95c1a70a54252274dc8f51
ToppCell	Parenchyma_Control_(B.)-Immune-TX-MoAM-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	CREM NAMPT MAFB MX2 SORL1	7.64e-05	200	97	5	59b2ebb69699c9bebf8c2697eb678fdccd0a998c
ToppCell	Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	PEG3 PTH1R KCNJ6 GPC4 UNC5D	7.64e-05	200	97	5	12326cc6f0af24bacba9493dc79e7c7347db2f41
ToppCell	mild-HLA-DR+_CD83+_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RXRA NAMPT RASGEF1B MAFB PLEC	7.64e-05	200	97	5	934c2efc780318c66d667ca75be0de350361d351
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	CEP85L AFF3 PCDH17 CCNY ADGRL2	7.64e-05	200	97	5	bcd1cc96197929d6011903803b6f4ccdcf52b4ce
ToppCell	Lung_Parenchyma-Control-Myeloid-MoAM-MoAM-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CREM NAMPT MAFB MX2 SORL1	7.64e-05	200	97	5	390f9429feae991b8524e2815d8fcd4914c74459
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYO9A PTH1R TGFB2 SMARCA4 PLXNA1	7.64e-05	200	97	5	ddfb1f006365bf16203ee49f20200f68220cc288
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CEP85L AFF3 PCDH17 CCNY ADGRL2	7.64e-05	200	97	5	b7533c571eeea0cb3678e1a57d3dc036fa8d0f49
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	AFF3 PCDH17 CCNY PLEC ADGRL2	7.64e-05	200	97	5	7034f57e282982c19c13ee8ab78eabaffa069e30
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PCDH17 CCNY SMARCA2 PLEC ADGRL2	7.64e-05	200	97	5	b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	PTH1R TGFB2 GPC4 PAK3 PCDH18	7.64e-05	200	97	5	a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCell	control-Neutrophil\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	JDP2 RXRA CCNY NAMPT MAFB	7.64e-05	200	97	5	b5d197472799cc61d7497faed91ac2564ae4930a
ToppCell	mild-B_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	IKZF3 BEND5 AFF3 STX7 EIF2AK3	7.64e-05	200	97	5	222789b897e2a683bbfd1d00b6fd8705015d90df
ToppCell	Lung_Parenchyma-Control-Myeloid-MoAM-MoAM\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CREM NAMPT MAFB MX2 SORL1	7.64e-05	200	97	5	f7e9b4a8ededb116774528b38ea3381b6f05915c
ToppCell	severe-Non-classical_Monocyte\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	JDP2 RXRA NAMPT RASGEF1B MAFB	7.64e-05	200	97	5	804c6e998fb7a29ca1b98f53d5dbcb7ae5a47e7a
ToppCell	Lung_Parenchyma-Control-Myeloid-MoAM\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	CREM NAMPT MAFB MX2 SORL1	7.64e-05	200	97	5	d98c523ac0e4767aaeef50cae142513d115212ab
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-B\|COVID-19_Mild / Disease, condition lineage and cell class	IKZF3 BEND5 AFF3 STX7 EIF2AK3	7.64e-05	200	97	5	11b51dfca161342d92126e0a83d10864348ba3ef
ToppCell	mild-B_naive\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	IKZF3 BEND5 AFF3 STX7 EIF2AK3	7.64e-05	200	97	5	d0467cab6a42bf780aa49046bf3231ca161dc144
ToppCell	Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Adora2a\|Striatum / BrainAtlas - Mouse McCarroll V32	IKZF3 ZNF804A MYO3B ABCC12	9.50e-05	109	97	4	e8e0f2c5f8c9e45f2b4d173569c94275eedfe432
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3_(Neuron.Gad1Gad2.Cplx3)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	USP26 MYO3A MYO3B	2.10e-04	53	97	3	9c6aba539d540211b2309da1af6a531f3275a49d
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3_(Neuron.Gad1Gad2.Cplx3)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	USP26 MYO3A MYO3B	2.10e-04	53	97	3	846e031024ad3a4f5c6640b61cf4a0e69dbbcd1c
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	ZNF438 RBBP6 ZNF804A JMJD1C	2.16e-04	135	97	4	3351e8b9e417397c5fa9f856184ff24ce1a27242
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Itm2a\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ZNF804A HOXA13 MAFB NXPH2	2.77e-04	144	97	4	0bbe670454846cf9bc7464ae4e91488415c4111d
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTSL1 SLC35F3 KCNJ6 NXPH2	2.92e-04	146	97	4	ec1f793409d1a81c0f9323eb3c82ffe01dae0e44
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	BEND5 WNT9A CARD9 UNC5D	3.15e-04	149	97	4	4b44108c40376a6b73258df40d2424e68f991383
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-9\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BEND5 AFF3 ZNF395 GPC4	3.32e-04	151	97	4	2314c004434aed9b7fa1ad01c61c43e5ed4a18ce
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	PCDH17 NAMPT MX2 SORL1	3.32e-04	151	97	4	b698ddc74565d47892c09c3f16d78038da2dd5e7
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PCDH17 MYO3B GPC4 PCDH18	3.40e-04	152	97	4	8ff5a178a8f3550d89a003c0858820aab3773386
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PCDH17 TGFB2 MYO3A MYO3B	3.40e-04	152	97	4	fed80b467ec9e30c7f98bed6cc4f8c583b715e9e
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HTR2B MYO3B PAK3 FGFBP1	3.57e-04	154	97	4	1e32969bee810adaf2d560f0824a16227df513d8
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(NPW+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HOXA13 SLC35F3 TTLL6 KCNJ6	3.66e-04	155	97	4	498e52e2364ff44d3c0c707ba22468217031f5bd
ToppCell	5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AFF3 ZNF804A MYO3B SORL1	3.75e-04	156	97	4	203ef22eb76bd2b829b027c30af0557080f4006c
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Pld5\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	WNT9A RASGEF1B ADGRL2 UNC5D	4.03e-04	159	97	4	a082e770fa757c4a1d3ed13d53f83297e36faf05
ToppCell	droplet-Heart-nan-24m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATXN7L2 PCDH18 PLXNA1 SORL1	4.03e-04	159	97	4	7ad3a91d29639b32f6264c91f401c14a35469ac0
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATXN7L2 CCDC146 BEND5 SORL1	4.23e-04	161	97	4	9f02b94e29e60d50e92eaa748ebf0c36d3671bb3
ToppCell	Healthy_Control-Lymphoid-B-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	IKZF3 BEND5 AFF3 GRAMD1C	4.43e-04	163	97	4	d84bd41b4494c7d5c7f88d511bfe481fb12f079d
ToppCell	Healthy_Control-Lymphoid-B\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	IKZF3 BEND5 AFF3 GRAMD1C	4.43e-04	163	97	4	0f723ec2503afa1b3ebb0754972438ffb6e6179d
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ZNF804A PTH1R MAFB NXPH2	4.63e-04	165	97	4	d8df50f5a3b646e8ea13739fdc65ce6f39b4d4d2
ToppCell	(0)_Myeloid-(00)_Monocyte-(000)_CD14+_Monocyte\|(00)_Monocyte / immune cells in Peripheral Blood (logTPM normalization)	IL13RA1 CCNY NAMPT SORL1	4.85e-04	167	97	4	7d9fd6a7a45c2aa0d5f2e3960ca4c97ee8836ba5
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TGFB2 MYO3B PAK3 FGFBP1	4.85e-04	167	97	4	cf6206c506715cd846799c62cf7c06e3fa99f7af
ToppCell	droplet-Liver-Npc-18m-Lymphocytic-B_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IKZF3 BEND5 AFF3 SLC35F3	4.96e-04	168	97	4	ce9fae8b295c668b0959d5007a8bcd401d80e258
Disease	vital capacity	ZNF438 ADAMTSL1 ZSCAN31 AFF3 WNT9A JMJD1C STX1B TGFB2 CARD9 KCNJ6 BRD4 SMARCA2 ADGRL2 EIF2AK3 PLXNA1	8.20e-06	1236	94	15	EFO_0004312
Disease	forced expiratory volume	ADAMTSL1 ZSCAN31 AFF3 JMJD1C STX1B TGFB2 NOL4L CARD9 SMARCA2 ADGRL2 EIF2AK3	4.28e-05	789	94	11	EFO_0004314
Disease	Clear Cell Sarcoma of Soft Tissue	CREB1 ATF1	6.00e-05	4	94	2	C0206651
Disease	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	SMARCA2 SMARCA4	9.98e-05	5	94	2	C3281201
Disease	cognitive function measurement, self reported educational attainment	ATXN7L2 AFF3 ZNF804A JMJD1C PCDH17 PRR12 NOL4L	1.44e-04	355	94	7	EFO_0004784, EFO_0008354
Disease	physical activity	OR6B1 ADAMTSL1 RBBP6 CCDC27	1.84e-04	88	94	4	EFO_0003940
Disease	birth measurement, spontaneous preterm birth	ADGRL2 SORL1	2.09e-04	7	94	2	EFO_0006917, EFO_0006921
Disease	opportunistic bacterial infectious disease (implicated_via_orthology)	SMARCA2 SMARCA4	3.56e-04	9	94	2	DOID:0050340 (implicated_via_orthology)
Disease	aortic aneurysm	IL13RA1 TGFB2	4.44e-04	10	94	2	EFO_0001666
Disease	CXCL5 measurement	BRD3 JMJD1C	4.44e-04	10	94	2	EFO_0009422
Disease	C-X-C motif chemokine 5 measurement	BRD3 JMJD1C	4.44e-04	10	94	2	EFO_0008058
Disease	disposition index measurement, glucose homeostasis measurement	ZNF438 SOHLH2	4.44e-04	10	94	2	EFO_0006832, EFO_0006896
Disease	diet measurement	OR6B1 ZSCAN31 ANK3 SKIDA1 JMJD1C PCDH17 SMARCA2 SMARCA4 ADGRL2 UNC5D SORL1	5.08e-04	1049	94	11	EFO_0008111
Disease	free cholesterol in large LDL measurement	JMJD1C SMARCA4 MAFB	5.84e-04	51	94	3	EFO_0022176
Disease	metabolite measurement, body weight gain	TACC2 ACSM4	6.49e-04	12	94	2	EFO_0004566, EFO_0004725
Disease	Coffin-Siris syndrome	SMARCA2 SMARCA4	7.65e-04	13	94	2	C0265338
Disease	cholesterol in IDL measurement	JMJD1C SMARCA4 MAFB	8.51e-04	58	94	3	EFO_0021899
Disease	schizophrenia, intelligence, self reported educational attainment	AFF3 BRD3 CREB1 ZNF804A PCDH17 SMARCA2	8.52e-04	346	94	6	EFO_0004337, EFO_0004784, MONDO_0005090
Disease	total lipids in IDL	JMJD1C SMARCA4 MAFB	9.39e-04	60	94	3	EFO_0022161
Disease	lifestyle measurement	AFF3 ZNF804A PCDH17 RASGEF1B SMARCA2	9.48e-04	235	94	5	EFO_0010724
Disease	free cholesterol in IDL measurement	JMJD1C SMARCA4 MAFB	9.86e-04	61	94	3	EFO_0022181
Disease	sporadic amyotrophic lateral sclerosis	ADAMTSL1 ANK3 ABCC12 PLXNA1	1.06e-03	140	94	4	EFO_0001357
Disease	Alzheimer disease, educational attainment	AFF3 JMJD1C PCDH17 SMARCA2 SORL1	1.18e-03	247	94	5	EFO_0011015, MONDO_0004975
Disease	reaction time measurement	TACC2 RXRA PTH1R PCDH17 BRD4 RASGEF1B CCAR1 ADGRL2	1.21e-03	658	94	8	EFO_0008393
Disease	Epstein-Barr virus infection	ARMT1 SLC22A15 SLC35F3	1.24e-03	66	94	3	EFO_0000769
Disease	dyslexia	CEP85L SMARCA2 ADGRL2 UNC5D	1.82e-03	162	94	4	EFO_0005424
Disease	cognitive function measurement	ZNF438 ATXN7L2 CCDC146 AFF3 BRD3 ZNF804A JMJD1C RXRA PCDH17 PRR12 MYO3A NOL4L	1.99e-03	1434	94	12	EFO_0008354
Disease	neuroimaging measurement	ZNF438 ANK3 AFF3 SKIDA1 TACC2 CREB1 JMJD1C SMARCA2 PLEC EIF2AK3	2.16e-03	1069	94	10	EFO_0004346
Disease	Drug toxicity	HTR2B GC ABCC12	2.48e-03	84	94	3	C0013221
Disease	Adverse reaction to drug	HTR2B GC ABCC12	2.48e-03	84	94	3	C0041755
Disease	cup-to-disc ratio measurement	ADAMTSL1 ANK3 TGFB2 NOL4L CCAR1 PLXNA1	2.56e-03	430	94	6	EFO_0006939
Disease	intermediate density lipoprotein measurement	JMJD1C SMARCA4 MAFB	2.73e-03	87	94	3	EFO_0008595
Disease	S-6-hydroxywarfarin to S-warfarin ratio measurement	GC TACC2 ZNF804A	2.82e-03	88	94	3	EFO_0803332
Disease	Crohn's disease	IKZF3 CCDC146 CREM RXRA CCNY CARD9	2.90e-03	441	94	6	EFO_0000384
Disease	multiple sclerosis	ZNF438 ADAMTSL1 IKZF3 JDP2 SMARCA4 ATF1 PLEC	2.93e-03	594	94	7	MONDO_0005301

Protein segments in the cluster

Peptide	Gene	Start	Entry
SRCVSYNREKQLKLK	USP26	211	Q9BXU7
KSCKNEERREAKYNL	BEND5	406	Q7L4P6
KSKRKRKCDNEDDYR	AFF3	816	P51826
CKKTREKASATRVYI	ARMT1	236	Q9H993
IKRKRNSEVKYTEAC	FAM200B	6	P0CF97
TCNYRATKSVKTLRK	HTR2B	396	P41595
LRELERYVKSCLQKK	BRD3	626	Q15059
QKCRLRVSTDLKYRK	GRAMD1C	446	Q8IYS0
VKTRYDTRQRKCPKC	RNF20	946	Q5VTR2
KNKVDDCNYAIKRIR	EIF2AK3	611	Q9NZJ5
ELERYVTSCLRKKRK	BRD4	666	O60885
TKRDDKRDINRYCKE	CCAR1	891	Q8IX12
KRDINRYCKERPSKD	CCAR1	896	Q8IX12
RSQKDICRYSKTAVK	FGFBP1	121	Q14512
QKREKTCRAYLKAIV	ADGRL2	596	O95490
KDILYRLRASKAKCI	ACSM4	151	P0C7M7
DKYKDLRRSARKRSA	CCNY	311	Q8ND76
KESFENYRRKRALRK	CARD9	496	Q9H257
SESIKKRACRYLLQR	ATG2B	6	Q96BY7
EEVAKKRKNLATYCR	ATXN7L2	666	Q5T6C5
SKSICEFDYLRKRRK	CCDC27	191	Q2M243
NCRIEYEKTDRAKKT	NXPH2	186	O95156
KRENKEIRTYNCRIA	PCDH17	731	O14917
REKKDTRSYNCRVAE	PCDH18	726	Q9HCL0
STLYRNTDRQRKKSK	PAK3	246	O75914
RLARERDAYKVKCEK	MAFB	286	Q9Y5Q3
KSKSCSEVRRLYVSK	GPC4	26	O75487
RKIQRYVRKDGKCNV	KCNJ6	51	P48051
CYKAKERKSSRDKEL	JMJD1C	1871	Q15652
AARCRNKKKERTEFL	JDP2	86	Q8WYK2
RDTTRYCEKVKQLKL	ADAMTSL1	1731	Q8N6G6
AYKRKSRDADRTLKR	PLXNA1	1266	Q9UIW2
AYKRKTQDADRTLKR	PLXNA3	1241	P51805
KDNRCRYILKTKFRE	NLRP2	156	Q9NX02
QERARKRIRTYLKSC	NOL4L	231	Q96MY1
NDKSCYSERKKTRNL	RASGEF1B	241	Q0VAM2
SLKRRQKTYNKEKLC	PEG3	671	Q9GZU2
RIRVKTNKLCYEDDK	IL13RA1	311	P78552
EYKKIQKERRRSFSR	RBBP6	671	Q7Z6E9
SYQENCRKRKISSKD	FRG2C	91	A6NGY1
KCLKNEYVENRTKSR	CMC2	46	Q9NRP2
RSRDRKKKSDANASY	ANK3	31	Q12955
KTRDRYISSLKKKCQ	CEP85L	481	Q5SZL2
EAARECRRKKKEYVK	CREB1	281	P16220
YKQRSSLEEHKERCR	IKZF3	211	Q9UKT9
NREAAKECRRRKKEY	CREM	296	Q03060
KTKKLYIDSRARRNL	SEC22B	121	O75396
YLIAKRNRKLKCTFS	SLC22A15	266	Q8IZD6
RTVRKDLTYTCRDNK	RXRA	161	P19793
PSVSCRKRYSKDRKD	LGSN	361	Q5TDP6
VSRLKRRSKDLNCLY	MTBP	731	Q96DY7
KTQKLRYRRCSSELL	PRR14L	1631	Q5THK1
CSFSREKKLDYLKRA	UPP2	231	O95045
DLIRKTDRSYKVKSR	SORL1	1971	Q92673
YKDRIRKKESEVLCS	TDRD6	1161	O60522
NSKAYKRSKRQTLRE	SMARCA2	411	P51531
RAADYQRKSRKTLCI	STX7	226	O15400
SIRKRLKLCADFKRT	TAF1	841	P21675
KRERYISECKKRAEE	ODAD3	296	A5D8V7
LYTSCKTERVLKTKR	SKIDA1	91	Q1XH10
AKAYKRSKRQSLREA	SMARCA4	436	P51532
YFECREKKTENSKLR	NAMPT	36	P43490
KYKNRVRSRISNLKD	TCEA1	186	P23193
ENVNKKDYVRVCARK	PRR12	1651	Q9ULL5
RHLCKKQRSEAYSER	ABCC12	461	Q96J65
RNREVKEALKKLAYC	OR6B1	291	O95007
YATNKFITKDKRRRI	HOXA13	341	P31271
CKSTEKQSVKQRYRE	SLC35F3	121	Q8IY50
RTIRKDLTYSCRDNK	RXRB	231	P28702
KKKKCEIYRRLREFA	CCDC146	501	Q8IYE0
RRKKKEYVKCLENRV	ATF1	231	P18846
RESACQSRRKKKEYL	ATF6B	336	Q99941
TNRRKKRALDAAYCF	TGFB2	296	P61812
SLDSKYRETCKRDSK	ZSCAN31	211	Q96LW9
YRETCKRDSKAEKQQ	ZSCAN31	216	Q96LW9
KECKKTFTLYRNLTR	ZNF573	361	Q86YE8
CRTKFKSLQLSYRKV	ZSCAN32	306	Q9NX65
RCDTRQQYRKLLKST	PTH1R	396	Q03431
CKLYSEQRAIRVKRV	STX18	146	Q9P2W9
TQSKYRDRCKDRIQR	STX1B	136	P61266
RRSKRNRKCPVKFDD	ZBTB41	251	Q5SVQ8
EDRKSVRYTRQKKSL	TRIM15	311	Q9C019
KRYSRSLTIAEFKCK	TBCB	26	Q99426
ARKARGEAKKCRKVY	ZNF395	476	Q9H8N7
ALERGRDYEKNKVCK	GC	16	P02774
KTYKCNECRKTFSRR	ZNF808	481	Q8N4W9
LKRCAQEYLSRVKKE	TACC2	2856	O95359
QKLQEALRRKYSCDR	PLEC	876	Q15149
RKKKRLVINLSSCRY	TTLL6	56	Q8N841
KSRKASVRIAYLRKN	UNC5D	146	Q6UXZ4
RCERFLQKSYRKLEK	WDR93	646	Q6P2C0
YKACDRLKLERKQRR	WNT9A	56	O14904
HSSKEKLRRERIKYC	SOHLH2	206	Q9NX45
RKYIINKCRDGKERV	ZNF438	401	Q7Z4V0
QRYKNISCKIRETEK	ZNF804A	546	Q7Z570
RRRSQFSSRKYLKKE	MX2	11	P20592
CSRRYQKIQEKRKES	MYO3A	1071	Q8NEV4
YDARRKFKKISNRRN	MYO3B	1101	Q8WXR4
RCKEEKYSITRKNPR	MYO9A	761	B2RTY4